Faculty Profiles

Arseniy Yashkin, PhD, is an Associate Professor in the School of Health Administration at Texas State University. He completed all of his education at the University of South Florida in Tampa where he earned a Bachelor of Arts in Economics, magna cum laude, in 2000, with a minor in Philosophy and a Certificate in Russian Studies. He went on to earn a Master of Public Health in 2002 and a Master of Arts in Economics in 2006. In 2013 he completed a Doctor of Philosophy in Public Health with a concentration in Health Services Research. His dissertation, which was cited in a 2019 World Health Organization report on alcohol control policy in Russia, examined the dynamics of alcohol consumption in the Russian Federation and the implications of price-related policies for controlling alcohol use.

After completing his doctorate, Dr. Yashkin joined Duke University as a Research Associate in the Department of Economics in Trinity College of Arts and Sciences. In 2015 he moved to Duke’s Biodemography of Aging Research Unit as a Research Scientist. He rose to Senior Research Scientist in 2020, the same year he joined the unit’s hiring committee, and was named Associate Research Professor in 2024. In 2026, following more than a decade at Duke, he joined the faculty of Texas State University.

Over his career, Dr. Yashkin has contributed as a co-investigator, senior investigator, or investigator to sixteen completed externally funded research projects. Their sponsors include the National Institutes of Health, the Department of Defense, the Patient-Centered Outcomes Research Institute, and the Bladder Cancer Advocacy Network. His work funded by the National Institute on Aging examined racial and geographic disparities in the risk and survival of Alzheimer’s disease and related dementias, geographic disparities in mortality and multimorbidity across the United States, Alzheimer’s disease in the context of aging, the genetics of aging, health, and longevity, genetic changes in population age structure and their implications for forecasting Alzheimer’s disease, and bioinformatics approaches to repurposing drugs for Alzheimer’s disease. For the Department of Defense, he helped examine the relationship between traumatic brain injury and Alzheimer’s disease. His earlier projects compared guideline-concordant care with active surveillance for ductal carcinoma in situ, estimated the cost of bladder cancer to Medicare, and studied visual impairment among older adults, the deterrence of drunk driving, the effects of drug treatment courts, and social influences on malaria prevention in sub-Saharan Africa.